Document Detail

Pharmacokinetics of pheniramine (Avil) and metabolites in healthy subjects after oral and intravenous administration.
MedLine Citation:
PMID:  3988394     Owner:  NLM     Status:  MEDLINE    
The pharmacokinetics of pheniramine and its two metabolites (N-desmethyl pheniramine and N-didesmethyl pheniramine) were determined in six healthy male subjects after intravenous (n = 3) or oral (n = 3) administration (30.5 mg of pheniramine - free base). Serum and urine levels were measured by HPLC. After i.v. administration, serum concentrations of pheniramine between 231 and 894 ng/ml were reached and after oral administration peak serum concentrations between 173 and 274 ng/ml were reached after 1-2.5 h. AUC values up to 72 h were 3035-4662 (i.v.) and 3507-5768 (ng/ml X h) (oral). The terminal half-lives were estimated to range between 8 and 17 h (i.v.) and 16 and 19 h (oral). Serum levels of the N-desmethyl derivative remained very low (up to 21 ng/ml), but were still detectable after 72 h. Serum levels of the N-didesmethyl derivative were below the detection limit. The amount of pheniramine excreted in the urine for up to 120 h varied between 5.7 and 11.6 mg and 10.2 and 13.2 mg after i.v. and oral administration respectively. Unlike the serum, considerable fractions of the drug occurred as metabolites in urine. Values were 8.1-16.4 mg (i.v.) and 7.4-13.3 mg (oral) for N-desmethyl pheniramine, 0.4-2.9 mg (i.v.) and 0.2-0.8 mg (oral) for N-didesmethyl pheniramine.
P U Witte; R Irmisch; P Hajdú
Related Documents :
11348484 - Pharmacokinetics and pharmacodynamics of antiulcer agents in llama.
21331564 - The effect of dietary vanadium on cell cycle and apoptosis of liver in broilers.
9673574 - Chloramphenicol pharmacokinetics after intravenous and intramuscular administration in ...
19371314 - Influence of food intake on the bioavailability and efficacy of oral calcitonin.
1729854 - A multicenter, randomized, double-blind, placebo-controlled trial of pimobendan, a new ...
8918034 - Allopurinol in the treatment of zoonotic cutaneous leishmaniasis.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of clinical pharmacology, therapy, and toxicology     Volume:  23     ISSN:  0174-4879     ISO Abbreviation:  Int J Clin Pharmacol Ther Toxicol     Publication Date:  1985 Jan 
Date Detail:
Created Date:  1985-06-06     Completed Date:  1985-06-06     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8003415     Medline TA:  Int J Clin Pharmacol Ther Toxicol     Country:  GERMANY, WEST    
Other Details:
Languages:  eng     Pagination:  59-62     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Oral
Injections, Intravenous
Middle Aged
Pheniramine / administration & dosage,  analogs & derivatives,  blood,  metabolism*
Reg. No./Substance:
19428-44-5/N-desmethylpheniramine; 19428-45-6/N-didesmethylpheniramine; 86-21-5/Pheniramine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Comparative study on renal accumulation of aminoglycoside antibiotics.
Next Document:  A pilot study of the pharmacokinetics and triglyceride lowering activity of acipimox in dialyzed ure...